Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-26-033669
Filing Date
2026-05-11
Accepted
2026-05-11 17:18:28
Documents
79
Period of Report
2026-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q arvn-20260331.htm   iXBRL 10-Q 965588
2 EX-31.1 arvn-20260331x10qex311.htm EX-31.1 10441
3 EX-31.2 arvn-20260331x10qex312.htm EX-31.2 10742
4 EX-32.1 arvn-20260331x10qex321.htm EX-32.1 5171
5 EX-32.2 arvn-20260331x10qex322.htm EX-32.2 5087
11 arvn-20260331_g1.jpg GRAPHIC 134213
  Complete submission text file 0001628280-26-033669.txt   6466942

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT arvn-20260331.xsd EX-101.SCH 54649
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT arvn-20260331_cal.xml EX-101.CAL 59094
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT arvn-20260331_def.xml EX-101.DEF 207219
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT arvn-20260331_lab.xml EX-101.LAB 637897
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT arvn-20260331_pre.xml EX-101.PRE 428742
83 EXTRACTED XBRL INSTANCE DOCUMENT arvn-20260331_htm.xml XML 693546
Mailing Address 395 WINCHESTER AVE 5 SCIENCE PARK NEW HAVEN CT 06511
Business Address 395 WINCHESTER AVE 5 SCIENCE PARK NEW HAVEN CT 06511 203-535-1456
ARVINAS, INC. (Filer) CIK: 0001655759 (see all company filings)

EIN.: 472566120 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38672 | Film No.: 26964507
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)